Theravance Biopharma, Inc. (TBPH) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$9,499
Total Return
-5.01%
CAGR
-1.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.78% |
| Median | +0.59% |
| Best | +61.78% |
| Worst | -49.70% |
| % of Windows Positive | 52.4% |
1-Year (252 Trading Days)
| Average | +16.33% |
| Median | +5.31% |
| Best | +141.94% |
| Worst | -53.79% |
| % of Windows Positive | 58.9% |
3-Year (756 Trading Days)
| Average | +21.32% |
| Median | +20.41% |
| Best | +95.38% |
| Worst | -55.02% |
| % of Windows Positive | 71.7% |
Risk Metrics
| Maximum Drawdown | -63.87% |
| Average Drawdown | -42.43% |
| Drawdown Duration | 1118 Trading Days |
| Sortino Ratio | 0.32 |
| Calmar Ratio | -0.02 |
| CVaR (5%) | -7.04% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -14.91% (-31.82% ann.) | $1491.17 | $0.00 | $0.00 | $0.00 |
| 2025 | +98.83% | +$9883.10 | $0.00 | $0.00 | $0.00 |
| 2024 | -16.28% | $1628.12 | $0.00 | $0.00 | $0.00 |
| 2023 | +0.18% | +$17.82 | $0.00 | $0.00 | $0.00 |
| 2022 | +1.54% | +$153.84 | $0.00 | $0.00 | $0.00 |
| 2021 | -37.82% | $3781.65 | $0.00 | $0.00 | $0.00 |
| 2020 | -31.36% | $3136.34 | $0.00 | $0.00 | $0.00 |
| 2019 | +1.17% | +$117.23 | $0.00 | $0.00 | $0.00 |
| 2018 | -8.25% | $824.67 | $0.00 | $0.00 | $0.00 |
| 2017 | -12.52% | $1251.57 | $0.00 | $0.00 | $0.00 |
| 2016 | +94.51% | +$9450.89 | $0.00 | $0.00 | $0.00 |
| 2015 | +9.85% | +$985.25 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -35.02% (-49.72% ann.) | $3501.74 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 16, 2014 – February 19, 2020 | +10.17% | +1.69% | +$1016.99 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -13.28% | -80.34% | $1328.19 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -28.67% | -41.94% | $2867.46 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -56.34% | -54.44% | $5633.92 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +29.76% | +31.87% | +$2976.19 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -27.02% | -15.63% | $2701.51 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +92.50% | +46.81% | +$9250.29 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.